Heart Health After Menopause: Risks, Warning Signs and Prevention

Heart disease is the leading cause of death in women, and risk rises notably after menopause. During the transition, LDL cholesterol rises, fat shifts toward the abdomen, and arteries become thicker and stiffer. Menopause doesn’t cause heart disease on its own, but it’s a key time to check blood pressure, cholesterol and blood sugar and to build heart-healthy habits.

Why does heart risk rise after menopause?

Women typically develop coronary heart disease several years later than men. In 2020, the American Heart Association (AHA) published a scientific statement concluding that the menopause transition itself is a time of accelerating cardiovascular risk, separate from the effects of aging.

According to the AHA and the SWAN study, changes around menopause include:

• Higher LDL ("bad") cholesterol
• More abdominal fat, which is linked with metabolic syndrome: a cluster of high blood pressure, high blood sugar, high triglycerides and low HDL cholesterol
• Thicker, stiffer arteries
• Changes in HDL cholesterol, which may become a less reliable sign of heart protection in midlife women

The AHA points out that menopause doesn’t cause cardiovascular disease directly. Rather, the changes that happen during the transition can increase risk.

How big is the risk?

The AHA notes that in the United States, about 1 in 3 women die from cardiovascular disease, compared with about 1 in 39 from breast cancer. Many people underestimate this. It’s also the leading cause of death for women worldwide.

With many women spending up to 40% of their lives postmenopausal, protecting heart health after menopause matters.

Which menopause-related factors are linked with higher risk?

• Early menopause. Menopause before 45, and especially before 40, is linked with higher cardiovascular risk. The 2024 international guideline on premature ovarian insufficiency notes that, without hormone therapy, POI is associated with reduced life expectancy, largely due to heart disease. See early menopause.
• Frequent or persistent hot flashes. Research from SWAN found that women with frequent or persistent hot flashes had a higher risk of later cardiovascular events. It recommends these women receive particular attention for heart risk reduction. See hot flashes.
• Depression. Depression during the transition is strongly linked with higher cardiovascular risk, according to the AHA. See low mood.
• Poor sleep. SWAN research has linked sleep patterns across midlife with later heart disease. See sleep problems.

Later natural menopause, by contrast, is associated with a lower risk of cardiovascular disease and death.

Does your reproductive history matter?

Yes. A review of the 2020 AHA statement notes that several reproductive factors are associated with higher cardiometabolic risk, including:

• Very early first periods
• Pregnancy complications, such as pre-eclampsia or gestational diabetes
• Preterm birth
• Early menopause

If any of these apply to you, mention them to your clinician. They can help build a more accurate picture of your heart risk.

What are the warning signs of a heart attack in women?

Chest pain or pressure is the most common symptom, but women are more likely than men to also have other symptoms, such as:

• Shortness of breath
• Nausea or vomiting
• Pain in the back, jaw, neck or arm
• Unusual tiredness, dizziness or cold sweats

Call emergency services immediately if you have:

• Chest pain, pressure or tightness, especially with breathlessness, sweating or nausea
• Sudden weakness or numbness in the face, arm or leg, trouble speaking, or confusion, which can be signs of a stroke
• Palpitations with chest pain, fainting or severe breathlessness

Palpitations are common around menopause and usually harmless, but new or persistent palpitations are worth checking.

Which checks matter after menopause?

• Blood pressure, at least every year or as advised
• Cholesterol, including LDL
• Blood sugar, such as an HbA1c test, to check for diabetes risk
• Weight and waist size
• An overall cardiovascular risk assessment, such as the NHS Health Check offered to adults aged 40 to 74 in England

See recommended health checks after menopause.

Know your numbers

Ask for your results and write them down, so you can track changes over time:

Healthy targets vary by country, age and other conditions, so your clinician will tell you what applies to you.

How can you protect your heart?

The AHA’s "Life’s Essential 8" sums up the key areas for heart health:

1. Eat well. Choose plenty of vegetables, fruit, whole grains, legumes, nuts and fish, and limit processed foods, salt and added sugar.
2. Be active. Aim for at least 150 minutes of moderate activity a week, plus strength training.
3. Don’t smoke or vape.
4. Sleep well. Aim for 7 to 9 hours, and get help for insomnia or snoring.
5. Manage weight, particularly around the waist.
6. Control cholesterol.
7. Control blood sugar.
8. Control blood pressure.

The AHA’s 2020 statement recommends counseling all women in midlife on these lifestyle changes. It also recommends considering cholesterol-lowering medicines where needed.

Sleep and your heart

Sleep is one of the AHA’s eight measures of heart health. SWAN research has linked sleep patterns across midlife with later cardiovascular events. If night sweats, snoring, insomnia or bladder symptoms disrupt your sleep, treating them may benefit your heart as well as your energy. Menopause-specific CBT is recommended by NICE for sleep problems linked to menopause.

What about hormone therapy and heart health?

The evidence depends heavily on timing:

• The AHA statement notes data suggesting that starting hormone therapy under 60 or within 10 years of menopause is associated with reduced cardiovascular risk.
• The Menopause Society notes that starting hormone therapy more than 10 years after menopause, or after 60, carries greater absolute risks of coronary heart disease, stroke and blood clots.
• Skin-applied estrogen, such as patches and gels, may carry a lower risk of blood clots and stroke than tablets.

Hormone therapy is not prescribed as a way to prevent heart disease on its own. Its main purpose is treating symptoms and preventing bone loss. But if you’re considering it, your heart health is part of the conversation.

Questions to ask your clinician

1. What is my overall cardiovascular risk?
2. Are my blood pressure, cholesterol and blood sugar in a healthy range?
3. Does my age at menopause or my hot flashes affect my risk?
4. Would a cholesterol-lowering medicine help me?
5. If I’m considering hormone therapy, how does my heart health affect the choice of type and route?

Frequently asked questions

Does menopause cause heart disease?

Not directly. But the menopause transition brings changes in cholesterol, body fat and blood vessels that increase cardiovascular risk.

Why does cholesterol go up after menopause?

LDL cholesterol rises around menopause as estrogen falls. Diet, activity and, if needed, medicines can help.

Does HRT protect your heart?

Starting hormone therapy under 60 or within 10 years of menopause is associated with reduced cardiovascular risk in some data. However, it isn’t prescribed solely for heart protection, and starting later carries greater risks.

Are hot flashes bad for your heart?

Research from SWAN links frequent or persistent hot flashes with higher later cardiovascular risk. It doesn’t mean hot flashes cause heart disease, but it’s a good reason to check your heart health.

References

1. El Khoudary SR et al. Menopause transition and cardiovascular disease risk: AHA scientific statement, 2020
2. Cleveland Clinic Journal of Medicine: Clinical impact of the 2020 AHA statement on menopause and CVD risk
3. American College of Cardiology: Key points from the AHA statement
4. American Heart Association: The connection between menopause and cardiovascular disease risks
5. American Heart Association newsroom: Menopause can impact a woman’s heart health (2024)
6. Medscape: New AHA scientific statement on menopause and CVD risk
7. SWAN: Cardiovascular risk and heart health during and after menopause
8. Thurston RC et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. Journal of the American Heart Association
9. ESHRE/ASRM/IMS: Evidence-based guideline on premature ovarian insufficiency, 2024
10. The 2022 hormone therapy position statement of The North American Menopause Society
11. NICE guideline NG23: Menopause, identification and management (CBT for sleep)
12. Let’s Talk Menopause: Summary of the NAMS 2022 position statement

Editorial status: evidence-based educational article. Last evidence check: September 10, 2026.